BioRestorative Therapies, Inc. (BRTX): Gross Profit
$335.9K
Year ended 2025-12-31
$329.6K
Trailing 12 months to 2026-03-31
-0.9%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $335.9K | -9.9% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $372.9K | +155.8% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $145.8K | n/a | 2025-03-28, From 2023-01-01 |
| No annual figure between 2017-12-31 and 2023-12-31. | |||
| 2017-12-31 | $81.0K | +123.4% | 2018-04-02, From 2017-01-01 |
| 2016-12-31 | $36.3K | -90.1% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $367.4K | +81.7% | 2017-03-22, From 2015-01-01 |
| 2014-12-31 | $202.2K | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $1.5K | -89.7% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $14.3K | n/a | 2014-04-11, From 2012-01-01 |
| 2011-12-31 | $0 | n/a | 2013-04-02, From 2011-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $335.9K | -9.9% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $250.4K | -34.1% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $24.19M | +0.6% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $155.46M | +16.7% |
| Sotera Health Co (SHC) | 2025-12-31 | $645.53M | +7.2% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $304.48M | +20.2% |
Compare BRTX, MGRX, CCEL, VMD side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗